Olympus Corporation

OTCPK:OCPNF

일본 / 헬스케어 / 의료 장비 및 용품

개요

뉴스

5년 과거 금융 데이터

주가

13.75 USD


Key Metrics	Latest
Total Revenue	985.7 B
Adjusted EBITDA	250.1 B
EBITDA Margin	25.4%
Net Profit Margin	13.8%
Total Assets	1,406.9 B
Total Debt	233.3 B

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Mar-20	Mar-21	Mar-22	Mar-23	Mar-24	12 Months	Dec-23	Dec-24

Revenue	797,411.00	730,544.00	868,867.00	881,923.00	936,210.00	985,717.00	675,714.00	725,221.00
% Growth		(0.08)	0.19	0.02	0.06			0.07

Adjusted EBITDA	158,287.00	160,805.00	233,165.00	238,825.00	180,162.00	250,091.00	88,524.00	158,453.00
% Margin	0.20	0.22	0.27	0.27	0.19	0.25	0.13	0.22

Adjusted EBIT	89,978.00	100,868.00	168,550.00	172,084.00	114,222.00	184,067.00	39,389.00	109,234.00
% Margin	0.11	0.14	0.19	0.20	0.12	0.19	0.06	0.15

Adjusted Net Income	56,830.56	29,169.84	127,916.56	133,227.84	294,925.84	136,235.82	235,575.00	76,884.98
% Margin	0.07	0.04	0.15	0.15	0.32	0.14	0.35	0.11

Adjusted Basic EPS	43.31	22.69	99.71	105.16	243.06	119.97	191.88	66.86

지원하는 계산법

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Press Release
JPY	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Mar-20	Mar-21	Mar-22	Mar-23	Mar-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	797,411	730,544	868,867	881,923	936,210	985,717	675,714	725,221
% Growth	NA	-8.4%	18.9%	1.5%	6.2%			7.3%

Cost of Revenue	(297,844)	(271,014)	(297,172)	(285,074)	(311,087)	(321,092)	(224,281)	(234,286)
Gross Profit	499,567	459,530	571,695	596,849	625,123	664,625	451,433	490,935
% Revenue	62.6%	62.9%	65.8%	67.7%	66.8%	67.4%	66.8%	67.7%

Research and Development	(91,600)	(81,800)	(85,300)	(76,900)	(86,400)	(86,400)	0	0
Selling and Marketing	(21,503)	(11,746)	(15,173)	(15,448)	(16,193)	(16,193)	0	0
General and Admin	(345,188)	(313,743)	(356,033)	(370,948)	(421,745)	(443,814)	(340,907)	(362,976)
Other Inc / (Exp)	38,421	27,388	38,365	50,866	(61,898)	(9,571)	(71,491)	(19,164)
Total Operating Exp	(419,870)	(379,901)	(418,141)	(412,430)	(586,236)	(555,978)	(412,398)	(382,140)

Operating Income	79,697	79,629	153,554	184,419	38,887	108,647	39,035	108,795
% Revenue	10.0%	10.9%	17.7%	20.9%	4.2%	11.0%	5.8%	15.0%

Interest Expense	(1,899)	(2,819)	(3,681)	(2,125)	(3,033)	(595)	(6,017)	(3,579)
Pre-tax Income	77,798	76,810	149,873	182,294	35,854	108,052	33,018	105,216
Earnings of Discontinued Ops.	0	(52,681)	0	5,623	215,956	(12,103)	228,086	27
Provision for Taxes	(26,143)	(11,140)	(33,903)	(44,304)	(8,881)	(12,211)	(25,529)	(28,859)
Net Income to Company	51,655	12,989	115,970	143,613	242,929	83,738	235,575	76,384
% Margin	6.5%	1.8%	13.3%	16.3%	25.9%	8.5%	34.9%	10.5%

Minority Interest in Earnings	15	(71)	(228)	(181)	(363)	0	(363)	0
Net Income to Stockholders	51,670	12,918	115,742	143,432	242,566	83,738	235,212	76,384

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	0	52,681	0	(5,623)	(215,956)	12,103	(228,086)	(27)

Net Income to Common	51,670	65,599	115,742	137,809	26,610	95,841	7,126	76,357
% Margin	6.5%	9.0%	13.3%	15.6%	2.8%	9.7%	1.1%	10.5%

As Reported
Basic EPS (Continuing Ops)	39.37	51.03	90.22	108.78	21.93	82.53	5.80	66.41
Diluted EPS (Continuing Ops)	39.36	51.00	90.17	108.65	21.88	82.38	5.79	66.29

WA Basic Shares Out.	1,312.29	1,285.61	1,282.92	1,266.85	1,213.40	1,135.56	1,227.70	1,149.86
WA Diluted Shares Out.	1,312.86	1,286.21	1,283.60	1,268.37	1,216.24	1,137.74	1,230.50	1,152.00

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	77,798	76,810	149,873	182,294	35,854	108,052	33,018	105,216
Addback: Net Interest Expense	1,899	2,819	3,681	2,125	3,033	595	6,017	3,579
Addback: Other Non Operating Expenses, Total	3,287	(627)	(1,148)	1,699	5,069	4,477	354	(238)
Addback: Depreciation & Amortization	68,309	59,937	64,615	66,741	65,940	66,024	49,135	49,219
Addback: Restructuring Charges	3,954	23,636	18,733	2,361	5,851	5,851	0	0
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	(1,770)	(2,826)	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	0	0	(1,393)	(16,395)	(1,127)	(1,127)	0	0
Addback: Asset Writedown	3,040	0	1,630	0	65,542	67,339	0	1,797
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	(1,120)	0	(1,120)
Addback: Other Unusual Items	0	0	0	0	0	0	0	0
Adjusted EBITDA	158,287	160,805	233,165	238,825	180,162	250,091	88,524	158,453
% Margin	19.9%	22.0%	26.8%	27.1%	19.2%	25.4%	13.1%	21.8%

Adjusted EBIT	89,978	100,868	168,550	172,084	114,222	184,067	39,389	109,234
% Margin	11.3%	13.8%	19.4%	19.5%	12.2%	18.7%	5.8%	15.1%

Adjusted Net Income Reconciliation
Net Income to Company	51,655	12,989	115,970	143,613	242,929	83,738	235,575	76,384
Addback: Unusual Items	6,994	21,866	16,144	(14,034)	70,266	70,943	0	677
Less: Tax Benefit of Unusual Items (26%)	(1,818)	(5,685)	(4,197)	3,649	(18,269)	(18,445)	0	(176)
Adjusted Net Income	56,831	29,170	127,917	133,228	294,926	136,236	235,575	76,885
% Margin	7.1%	4.0%	14.7%	15.1%	31.5%	13.8%	34.9%	10.6%

로딩 에러

Olympus Corporation

OTCPK:OCPNF

일본 / 헬스케어 / 의료 장비 및 용품

5년 과거 금융 데이터